All products / DC5041
CAT. NO. DC5041
DCC-2036 (Rebastinib)
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $500 USDRequest a quote / confirm availability → |
| 250 mg | $900 USDRequest a quote / confirm availability → |
| 1 g | $1,800 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
DCC-2036 is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1/2.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC5041 |
|---|---|
| Product name | DCC-2036 (Rebastinib) |
| CAS | 1020172-07-9 |
| Molecular formula | C30H28FN7O3 |
| Molecular weight | 553.59 |
| Purity | >98% |
| SMILES | CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — DCC-2036 (Rebastinib) (DC5041)